Abstract
INHIBITORS of the human immunodeficiency virus type 1 (HIV-1) protease have entered clinical study as potential therapeutic agents for HIV-1 infection. The clinical efficacy of HIV-1 reverse transcriptase inhibitors has been limited by the emergence of resistant viral variants. Similarly, variants expressing resistance to protease inhibitors have been derived in cell culture1-10. We now report the characterization of resistant variants isolated from patients undergoing therapy with the protease inhibitor MK-639 (formerly designated L-735,524). Five of these variants, isolated from four patients, exhibited cross-resistance to all members of a panel of six structurally diverse protease inhibitors. This suggests that com-bination therapy with multiple protease inhibitors may not prevent loss of antiviral activity resulting from resistance selection. In addition, previous therapy with one compound may abrogate the benefit of subsequent treatment with a second inhibitor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen, C. M. et al. J. Cell Biochem. 18D, 166 (1994).
El-Farrash, M. A. et al. J. Virol. 68, 233–239 (1994).
Ho, D. D. et al. J. Virol. 68, 2016–2020 (1994).
Jacobsen, H. et al. Virology 206, 527–534 (1995).
Kempf, D. J. et al. J. Cell Biochem. 18D, 130 (1994).
Markowitz, M. et al. J. Virol. 69, 701–706 (1995).
Otto, M. J. et al. Proc. natn. Acad. Sci. U.S.A. 90, 7543–7547 (1993).
Singh, M. K. et al. J. Cell Biochem. 17E, 86 (1993).
Tisdale, M. et al. Abstr. Third Int. Workshop HIV Drug Resistance, August 2–5, 1994, Kauai, Hawaii 14 (1994).
Winslow, D. L. et al. AIDS 8, 753–756 (1994).
Dorsey, B. D. et al. J. med. Chem. 37, 3443–3451 (1994).
Vacca, J. P. et al. Proc. natn. Acad. Sci. U.S.A. 91, 4096–4100 (1994).
Lam, P. et al. Science 263, 380–384 (1994).
Otto, M. J. et al. Antimicrob. Agents Chemother. 37, 2606–2611 (1993).
Kempf, D. J., Norbeck, D. W., Marsh, K. C. & Erickson, J. Abstr. Am. chem. Soc. 206, 119 (1993).
Craig, J. C. et al. Antivir. Res. 16, 295–305 (1991).
Tung, R. D. et al. Tenth Int. Conf. AIDS 33 (1994).
Getman, D. P. et al. J. med. Chem. 36, 288–291 (1993).
Myers, G., Wain-Hobson, S., Korber, B., Smith, R. F. & Pavlakis, G. N. Human Retroviruses and AIDS (Los Alamos National Laboratory, Los Alamos, New Mexico, 1993).
Navia, M. A. et al. Nature 337, 615–620 (1989).
Wlodawer, A. et al. Science 245, 616–621 (1989).
Saag, M. S. et al. New Engl. J. Med. 329, 1065–1072 (1993).
Chomczynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Colonno, R. J. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5449–5453 (1988).
Kohl, N. E. et al. Proc. natn. Acad. Sci. U.S.A. 85, 4686–4690 (1988).
Adachi, A. et al. J. Virol. 59, 284–291 (1986).
Byrnes, V. W. et al. Antimicrob. Agents Chemother. 37, 1576–1579 (1993).
Nunberg, J. H. et al. J. Virol. 65, 4887–4892 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Condra, J., Schleif, W., Blahy, O. et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569–571 (1995). https://doi.org/10.1038/374569a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/374569a0
This article is cited by
-
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure
Retrovirology (2021)
-
Drug resistance mutations in protease gene of HIV-1 subtype C infected patient population
VirusDisease (2021)
-
Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
Scientific Reports (2019)
-
HIV-1 immune evasion—a threat to effective vaccines?
Nature Medicine (2016)
-
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy
Gene Therapy (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
